IMMATICS BIOTECHNOLOGIES GMBH
IMTXW -0.31
EPS (as of 2023-12-31)
Use left/right arrow keys to switch.Breakdowns
| Name | Value |
|---|
| Revenues | 15.9M |
| Cost of Revenue | 33.3M |
| Gross Profit | -17.3M |
| Operating Expense | 43.6M |
| Operating I/L | -27.7M |
| Other Income/Expense | -3.1M |
| Interest Income | 4.9M |
| Pretax | -26.1M |
| Income Tax Expense | 0.2M |
| Net Income/Loss | -26.1M |
immatics biotechnologies GmbH
Trending Profiles
This is the ALPHA version. The tool and data may contain incorrect information. Please read it with caution.
